Ondansetron (Aspire Biopharma Holdings)

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameOndansetron (Aspire Biopharma Holdings)
Drug Alias Nameondansetron (Aspire Biopharma Holdings)
ClassificationSmall molecules
Mechanisms of ActionSerotonin 3 (5-HT3) receptor antagonists
TargetsSerotonin 3 (5-HT3) receptor
Therapy Area/IndicationsChemotherapy-induced nausea and vomiting
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAspire Biopharma Holdings Inc
China Registration ClassN/A

Develop Information

Active CompaniesAspire Biopharma Holdings Inc
Inactive CompaniesN/A
Active IndicationsChemotherapy-induced nausea and vomiting
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A